BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 16391873)

  • 21. The chemokines, CX3CL1, CCL14, and CCL4, promote human trophoblast migration at the feto-maternal interface.
    Hannan NJ; Jones RL; White CA; Salamonsen LA
    Biol Reprod; 2006 May; 74(5):896-904. PubMed ID: 16452465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity.
    Suck G; Branch DR; Smyth MJ; Miller RG; Vergidis J; Fahim S; Keating A
    Exp Hematol; 2005 Oct; 33(10):1160-71. PubMed ID: 16219538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes.
    Kobayashi T; Okamoto S; Iwakami Y; Nakazawa A; Hisamatsu T; Chinen H; Kamada N; Imai T; Goto H; Hibi T
    Inflamm Bowel Dis; 2007 Jul; 13(7):837-46. PubMed ID: 17285595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis.
    Fang IM; Lin CP; Yang CM; Chen MS; Yang CH
    Mol Vis; 2005 Jul; 11():443-51. PubMed ID: 16030495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The high expression of Fractalkine results in a better prognosis for colorectal cancer patients.
    Ohta M; Tanaka F; Yamaguchi H; Sadanaga N; Inoue H; Mori M
    Int J Oncol; 2005 Jan; 26(1):41-7. PubMed ID: 15586223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
    Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
    Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
    Lucas AD; Bursill C; Guzik TJ; Sadowski J; Channon KM; Greaves DR
    Circulation; 2003 Nov; 108(20):2498-504. PubMed ID: 14581400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis.
    Nanki T; Imai T; Nagasaka K; Urasaki Y; Nonomura Y; Taniguchi K; Hayashida K; Hasegawa J; Yoshie O; Miyasaka N
    Arthritis Rheum; 2002 Nov; 46(11):2878-83. PubMed ID: 12428227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane-bound form of fractalkine induces IFN-gamma production by NK cells.
    Yoneda O; Imai T; Nishimura M; Miyaji M; Mimori T; Okazaki T; Domae N; Fujimoto H; Minami Y; Kono T; Bloom ET; Umehara H
    Eur J Immunol; 2003 Jan; 33(1):53-8. PubMed ID: 12594832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS.
    Hughes PM; Botham MS; Frentzel S; Mir A; Perry VH
    Glia; 2002 Mar; 37(4):314-27. PubMed ID: 11870871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis.
    Yoshimoto S; Nakatani K; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Harada K; Akai Y; Shiiki H; Nose M; Saito Y
    Am J Kidney Dis; 2007 Jul; 50(1):47-58. PubMed ID: 17591524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel cooperation between CX3CL1 and CCL26 inducing NK cell chemotaxis via CX3CR1: a possible mechanism for NK cell infiltration of the allergic nasal tissue.
    El-Shazly AE; Doloriert HC; Bisig B; Lefebvre PP; Delvenne P; Jacobs N
    Clin Exp Allergy; 2013 Mar; 43(3):322-31. PubMed ID: 23414540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue.
    Hosokawa Y; Nakanishi T; Yamaguchi D; Nakae H; Matsuo T
    Clin Exp Immunol; 2005 Mar; 139(3):506-12. PubMed ID: 15730397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fractalkine-mediated endothelial cell injury by NK cells.
    Yoneda O; Imai T; Goda S; Inoue H; Yamauchi A; Okazaki T; Imai H; Yoshie O; Bloom ET; Domae N; Umehara H
    J Immunol; 2000 Apr; 164(8):4055-62. PubMed ID: 10754298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
    You JJ; Yang CH; Huang JS; Chen MS; Yang CM
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
    Klöss S; Bochennek K; Huenecke S; Zimmermann SY; Kuçi S; Müller T; Wels WS; Klingebiel T; Esser R; Koehl U
    J Immunol Methods; 2007 Aug; 325(1-2):140-7. PubMed ID: 17663991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients.
    Yano R; Yamamura M; Sunahori K; Takasugi K; Yamana J; Kawashima M; Makino H
    Acta Med Okayama; 2007 Apr; 61(2):89-98. PubMed ID: 17471309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fractalkine in vascular biology: from basic research to clinical disease.
    Umehara H; Bloom ET; Okazaki T; Nagano Y; Yoshie O; Imai T
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):34-40. PubMed ID: 12969992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.